查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2048185

液氧氧氣設備市場 - 全球產業規模、佔有率、趨勢、機會、預測：銷售管道、最終用途、地區和競爭格局，2021-2031年

Liquid Oxygen Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Distribution Channel, By End Use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球氧氣設備市場預計將從 2025 年的 66.1 億美元成長到 2031 年的 86.2 億美元，複合年成長率為 4.52%。

這些專為低溫儲存和供應高濃度氧氣而設計的專用醫療系統，對於需要長期呼吸支持的患者至關重要。這一成長主要受全球慢性阻塞性肺病（COPD）患病率上升和老年人口不斷成長的推動，這兩方面都持續推高了對持續氧氣療法的需求。其中一個關鍵因素是易患呼吸系統疾病的老年人口迅速增加，這使得先進的呼吸支持系統成為必要。除了人口結構的變化，嚴重肺部疾病的增加，包括結核病等主要感染疾病的流行趨勢（根據世界衛生組織統計，2023年全球結核病病例已達1080萬例），也迫使醫療系統加強其低溫基礎設施建設。同時，家庭長期氧氣療法的日益普及推動了攜帶式液態氧系統的發展，這些系統充分考慮了患者的活動能力，並正在重塑市場格局。從臨床照護到住宅照護的轉變顯著推動了醫療保健服務的成長，液化空氣集團2024年上半年醫療保健業務收入成長4.4%就證明了這一點。此外，專用儲存單元的生產也在加速，Chart Industries報告稱，2024年第三季銷售額成長22.4%至10.6億美元，凸顯了醫用氣體設備生產商業規模的不斷擴大。

市場概覽
預測期 2027-2031
市場規模：2025年 66.1億美元
市場規模：2031年 86.2億美元
複合年成長率：2026-2031年 4.52%
成長最快的細分市場 居家照護
最大的市場 北美洲

然而，液態氧設備產業面臨許多挑戰，這些挑戰源自於低溫供應鏈複雜的物流系統和巨額資本投入。維護包括空氣分離器、專用真空絕緣運輸車輛和低溫倉儲設施在內的複雜基礎設施需要大量的初始資金，這構成了很高的准入門檻，阻礙了業務的快速擴張，尤其是在發展中地區。這項基礎工業氣體市場規模龐大，預計2024年價值將達到869億歐元（EIGA），凸顯了其資源密集的特性。僅到2025年，該市場就將為美國經濟貢獻超過100億美元（CGA），但同時，它往往僅限於資金雄厚的大都會圈。儘管有這些障礙，市場趨勢顯示其正迎來充滿希望的轉型。物聯網賦能的遠端測量和智慧監控技術的整合，透過提供即時液位數據、最佳化配送路線以及確保氧氣持續供應，正在徹底改變供應鏈效率，從而提升患者安全。數位轉型正顯著推動醫療保健服務收入成長，液化空氣集團的醫療保健業務在2024年實現了8.6%的營收成長。同時，真空絕熱技術的進步對於延長液態氧的保存期限至關重要，其關鍵在於利用高性能材料和多層隔熱材料來最大限度地減少低溫蒸發損失。這項技術升級正推動對尖端低溫基礎設施的大量投資，並體現在先進設備的銷售成長上。 Chart Industries公司2025年第二季的營收年增4.0%，達到10.8億美元。

市場促進因素

老年人口的快速成長是液態氧設備市場的主要驅動力，持續推高了對大容量呼吸支援系統的需求。這項人口結構變化與需要持續醫用級氧氣輸送的嚴重肺部疾病發生率上升密切相關，迫使醫療系統儲備和升級低溫設備。全球感染疾病趨勢清楚地反映了日益加重的呼吸系統疾病負擔。根據世界衛生組織（世衛組織）於2024年10月發布的《2024年全球結核病報告》，2023年全球約有1,080萬人感染結核病。結核病的再次爆發凸顯了建立健全的氧氣基礎設施以應對急性和慢性呼吸系統危機的迫切需求。同時，對家庭長期氧氣療法的需求不斷成長，正在重塑市場格局，推動攜帶式、輕型液態氧系統的發展，使患者能夠在接受治療的同時保持行動能力。這種從臨床環境轉變為住宅環境的轉變也體現在主要產業參與者的表現中。根據液化空氣集團於2024年7月發布的《2024年上半年財務業績報告》，該公司醫療保健業務銷售額成長4.4%，主要得益於居家醫療服務的強勁發展。家庭醫療保健模式的激增直接推動了專用儲存單元的生產，這一趨勢在整個設備行業中普遍存在。根據Chart Industries的數據顯示，2024年第三季銷售額達10.6億美元，年增22.4%。這顯示低溫氣體和醫用氣體設備的生產規模正在擴大。

市場挑戰

維持低溫供應鏈所需的複雜物流和巨額資本投入是全球液態氧設備市場擴張的主要障礙。與典型的醫療設備不同，液態氧系統依賴一個複雜的網路，包括空氣分離器、專用真空絕緣運輸車輛以及能夠維持極低溫度的低溫倉儲設施。建造和維護這些基礎設施需要大量的初始資金，這構成了很高的進入門檻，阻礙了業務的快速擴張。這種資本密集要求尤其阻礙了醫療資源有限的發展中地區的市場成長。支持這些營運所需的龐大經濟規模往往限制了液態氧設備的供應，使其僅限於資金雄厚的大都會圈，而農村和經濟低度開發地區則無法獲得這些設備。根據壓縮氣體協會預測，到2025年，壓縮氣體產業將為美國經濟貢獻超過100億美元，這一數字顯示了支持該產業所需的巨大經濟影響和資源密集度。在缺乏這種成熟工業能力的市場，從零開始建立此類供應鏈的成本有效地阻礙了這些生命維持設備的廣泛應用。

市場趨勢

物聯網賦能的遠端測量和智慧監控的整合，正從根本上改變液氧設備市場，有效解決了供應鏈中存在的許多低效問題。與基於固定時間表的傳統配送模式不同，這些智慧系統利用感測器將液位資料即時傳輸給供應商，從而實現動態路線最佳化，避免危險的斷貨。這種數位化進步不僅降低了緊急配送的營運成本，還透過確保持續供應提升了病患安全。向數位化整合醫療模式的轉變所帶來的商業性影響，已在主要醫療服務提供者的業績中得到清晰體現。根據液化空氣集團於2025年2月發布的“2024會計年度業績報告”，該公司醫療保健業務收入成長了8.6%。這一業績成長主要歸功於以價值為導向的居家醫療模式的蓬勃發展，而這些模式正是利用了上述技術進步。同時，採用先進的真空絕熱技術對於緩解低溫環境下固有的蒸發損失問題至關重要，從而延長了液態氧的實際儲存壽命。製造商正擴大採用高性能材料和多層隔熱技術來生產儲存槽，以最大限度地減少熱傳遞，從而降低醫用氧氣長距離運輸和儲存的成本。隨著醫療機構更換老舊低效率的設備，這項技術升級正推動對先進低溫基礎設施的大量投資。領先設備製造商的銷售額也反映了對這些先進儲存解決方案的需求。根據Chart Industries於2025年7月發布的2025年第二季財報，該公司銷售額達10.8億美元，年增4.0%。這證實了市場對先進低溫技術以及據此設計和製造的設備越來越認可。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球氧氣設備市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 銷售管道（直銷、間接銷售）
    • 依用途（醫院、門診機構、居家醫療、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美氧氣設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲氧氣設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區液態氧氧氣設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲液態氧氧氣設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲氧氣設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章 全球氧氣設備市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • CAIRE Inc.
  • Cryofab Inc
  • Koninklijke Philips NV
  • Air Liquide SA
  • Inogen Inc
  • ErgoMed Inc.
  • Taylor-Wharton International LLC
  • Inova Labs Inc.
  • DeVilbiss Healthcare
  • NTK Oxygen Electronics Co. Ltd.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 20910

The Global Liquid Oxygen Devices Market is projected to expand from USD 6.61 Billion in 2025 to USD 8.62 Billion by 2031, demonstrating a 4.52% CAGR. These specialized medical systems, designed for cryogenic storage and delivery of high-concentration oxygen, are crucial for patients needing long-term respiratory support. This growth is primarily fueled by the increasing global prevalence of chronic obstructive pulmonary disease (COPD) and an expanding geriatric population, both driving a sustained demand for consistent oxygen therapy. A major catalyst is the rapidly growing elderly demographic, highly susceptible to respiratory disorders, which necessitates advanced respiratory support systems. This demographic shift, coupled with rising severe lung conditions, including significant infection trends like the 10.8 million tuberculosis cases worldwide in 2023 (WHO), compels healthcare systems to enhance cryogenic infrastructure. Concurrently, the increasing adoption of home-based long-term oxygen therapy is reshaping the market, fostering the development of portable liquid oxygen systems for patient mobility. This shift from clinical to residential care has notably supported growth in healthcare services, as evidenced by Air Liquide's 4.4% sales growth in their Healthcare business in H1 2024, and boosted manufacturing of specialized storage units, with Chart Industries reporting a 22.4% increase in Q3 2024 sales to $1.06 billion, highlighting the expanding commercial scale of medical gas device production.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 6.61 Billion
Market Size 2031USD 8.62 Billion
CAGR 2026-20314.52%
Fastest Growing SegmentHomecare
Largest MarketNorth America

However, the liquid oxygen devices sector faces a significant challenge stemming from the complex logistics and high capital investment demanded by the cryogenic supply chain. Maintaining this intricate infrastructure, which includes air separation units, specialized vacuum-insulated transport fleets, and cryogenic storage facilities, requires substantial upfront financial resources, thereby creating high entry barriers and impeding rapid scalability, especially in developing regions. The immense economic scale of this underlying industrial gas market, valued at €86.9 billion in 2024 (EIGA), underscores the resource intensity involved, contributing over $10 billion to the U.S. economy alone by 2025 (CGA) and often limiting access to well-funded metropolitan centers. Despite these hurdles, market trends show promising transformations. The integration of IoT-enabled telemetry and smart monitoring is revolutionizing supply chain efficiency by providing real-time tank level data, optimizing delivery routes, and ensuring continuous oxygen availability for enhanced patient safety. This digital shift has contributed to significant revenue growth in healthcare services, with Air Liquide's Healthcare business seeing an 8.6% increase in 2024. Concurrently, advancements in vacuum insulation technologies are crucial for extending liquid oxygen storage duration by minimizing cryogenic boil-off through high-performance materials and multi-layer insulation. This technological upgrade is driving substantial investment in modern cryogenic infrastructure and reflecting in increased sales of advanced equipment, as shown by Chart Industries' Q2 2025 sales of $1.08 billion, an increase of 4.0%.

Market Driver

The rapidly expanding geriatric population susceptible to respiratory disorders stands as a primary catalyst for the liquid oxygen devices market, creating sustained demand for high-capacity respiratory support systems. This demographic shift correlates with a rising incidence of severe lung conditions that require consistent, medical-grade oxygen delivery, pushing healthcare systems to stockpile and upgrade their cryogenic equipment. A clear indicator of this escalating respiratory burden is evident in global infection trends. According to the World Health Organization, October 2024, in the 'Global Tuberculosis Report 2024', approximately 10.8 million people fell ill with tuberculosis worldwide in 2023, a resurgence that underscores the critical need for robust oxygen infrastructure to manage acute and chronic respiratory crises. Simultaneously, the growing preference for home-based long-term oxygen therapy is reshaping the market, driving the development of portable and lightweight liquid oxygen systems that allow patients to maintain mobility while receiving care. This transition from clinical to residential settings is reflected in the performance of major industry players. According to Air Liquide, July 2024, in the 'First Half 2024 Financial Report', their Healthcare business posted sales growth of 4.4%, a rise explicitly supported by the dynamic development of home healthcare services. This surge in home-based modalities directly fuels the manufacturing of specialized storage units, as further evidenced by the broader equipment sector. According to Chart Industries, in 2024, the company reported third-quarter sales of $1.06 billion, marking a 22.4% increase that highlights the expanding commercial scale of cryogenic and medical gas device production.

Market Challenge

The complex logistics and high capital investment required to maintain a cryogenic supply chain represent a formidable barrier to the expansion of the Global Liquid Oxygen Devices Market. Unlike standard medical equipment, liquid oxygen systems rely on an intricate network involving air separation units, specialized vacuum-insulated transport fleets, and cryogenic storage facilities capable of maintaining extremely low temperatures. Establishing and sustaining this infrastructure necessitates substantial upfront financial resources, creating high entry barriers that prevent rapid scalability. This financial intensity particularly hampers market growth in developing regions where healthcare funding is constrained. The sheer economic scale required to support these operations limits the reach of liquid oxygen devices to well-funded metropolitan centers, often leaving rural or economically disadvantaged areas without access. According to the Compressed Gas Association, in 2025, the compressed gas industry contributed over $10 billion to the U.S. economy, a figure that illustrates the massive economic footprint and resource intensity essential for supporting this sector. In markets lacking this level of established industrial capability, the cost of building such a supply chain from scratch effectively stalls the broader adoption of these life-support devices.

Market Trends

The integration of IoT-enabled telemetry and smart monitoring is fundamentally transforming the liquid oxygen devices market by addressing critical supply chain inefficiencies. Unlike traditional delivery models based on fixed schedules, these smart systems utilize sensors to transmit real-time tank level data to suppliers, enabling dynamic route optimization and preventing dangerous stockouts. This digital evolution not only reduces operational costs associated with emergency deliveries but also enhances patient safety by ensuring continuous availability. The commercial impact of this shift toward digitally integrated care is evident in the performance of major healthcare providers. According to Air Liquide, February 2025, in the 'Full Year 2024 Financial Results', the company's Healthcare business revenue increased by 8.6%, a performance explicitly attributed to the dynamic development of value-based home healthcare models that leverage such technological advancements. Simultaneously, the adoption of advanced vacuum insulation technologies is crucial for mitigating the inherent issue of cryogenic boil-off, thereby extending the viable storage duration of liquid oxygen. Manufacturers are increasingly utilizing high-performance materials and multi-layer insulation techniques to construct storage tanks that minimize thermal transfer, making the long-distance transport and storage of medical oxygen more economically viable. This technological upgrade is driving substantial investment in modern cryogenic infrastructure as providers seek to replace aging, less efficient equipment. This demand for sophisticated containment solutions is reflected in the sales figures of leading equipment manufacturers. According to Chart Industries, July 2025, in the 'Second Quarter 2025 Financial Results', the company reported sales of $1.08 billion, an increase of 4.0% that underscores the growing market uptake of advanced cryogenic technologies and engineered equipment.

Key Market Players

  • CAIRE Inc.
  • Cryofab Inc
  • Koninklijke Philips N.V.
  • Air Liquide SA
  • Inogen Inc
  • ErgoMed Inc.
  • Taylor-Wharton International LLC
  • Inova Labs Inc.
  • DeVilbiss Healthcare
  • NTK Oxygen Electronics Co. Ltd.

Report Scope

In this report, the Global Liquid Oxygen Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Liquid Oxygen Devices Market, By Distribution Channel

  • Direct Sales
  • Indirect Sales

Liquid Oxygen Devices Market, By End Use

  • Hospitals
  • Outpatient Facilities
  • Homecare
  • Others

Liquid Oxygen Devices Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Liquid Oxygen Devices Market.

Available Customizations:

Global Liquid Oxygen Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Liquid Oxygen Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Distribution Channel (Direct Sales, Indirect Sales)
    • 5.2.2. By End Use (Hospitals, Outpatient Facilities, Homecare, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Liquid Oxygen Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Distribution Channel
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Liquid Oxygen Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Distribution Channel
        • 6.3.1.2.2. By End Use
    • 6.3.2. Canada Liquid Oxygen Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Distribution Channel
        • 6.3.2.2.2. By End Use
    • 6.3.3. Mexico Liquid Oxygen Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Distribution Channel
        • 6.3.3.2.2. By End Use

7. Europe Liquid Oxygen Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Distribution Channel
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Liquid Oxygen Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Distribution Channel
        • 7.3.1.2.2. By End Use
    • 7.3.2. France Liquid Oxygen Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Distribution Channel
        • 7.3.2.2.2. By End Use
    • 7.3.3. United Kingdom Liquid Oxygen Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Distribution Channel
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Liquid Oxygen Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Distribution Channel
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Liquid Oxygen Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Distribution Channel
        • 7.3.5.2.2. By End Use

8. Asia Pacific Liquid Oxygen Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Distribution Channel
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Liquid Oxygen Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Distribution Channel
        • 8.3.1.2.2. By End Use
    • 8.3.2. India Liquid Oxygen Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Distribution Channel
        • 8.3.2.2.2. By End Use
    • 8.3.3. Japan Liquid Oxygen Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Distribution Channel
        • 8.3.3.2.2. By End Use
    • 8.3.4. South Korea Liquid Oxygen Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Distribution Channel
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia Liquid Oxygen Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Distribution Channel
        • 8.3.5.2.2. By End Use

9. Middle East & Africa Liquid Oxygen Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Distribution Channel
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Liquid Oxygen Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Distribution Channel
        • 9.3.1.2.2. By End Use
    • 9.3.2. UAE Liquid Oxygen Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Distribution Channel
        • 9.3.2.2.2. By End Use
    • 9.3.3. South Africa Liquid Oxygen Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Distribution Channel
        • 9.3.3.2.2. By End Use

10. South America Liquid Oxygen Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Distribution Channel
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Liquid Oxygen Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Distribution Channel
        • 10.3.1.2.2. By End Use
    • 10.3.2. Colombia Liquid Oxygen Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Distribution Channel
        • 10.3.2.2.2. By End Use
    • 10.3.3. Argentina Liquid Oxygen Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Distribution Channel
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Liquid Oxygen Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. CAIRE Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Cryofab Inc
  • 15.3. Koninklijke Philips N.V.
  • 15.4. Air Liquide SA
  • 15.5. Inogen Inc
  • 15.6. ErgoMed Inc.
  • 15.7. Taylor-Wharton International LLC
  • 15.8. Inova Labs Inc.
  • 15.9. DeVilbiss Healthcare
  • 15.10. NTK Oxygen Electronics Co. Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer